Navigation Links
Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update
Date:3/27/2008

First Patient Dosed in Phase 1/2 Trial of TRU-016, Trubion's Proprietary

Product Candidate SBI-087 for RA Expands Trubion's Family of Customized, Differentiated

Product Candidates

SEATTLE, March 27 /PRNewswire-FirstCall/ -- Trubion Pharmaceuticals, Inc. (Nasdaq: TRBN) today announced that it has initiated a Phase 1/2 clinical trial of TRU-016, the company's lead proprietary Small Modular ImmunoPharmaceutical (SMIP(TM)) drug candidate, for the treatment of chronic lymphocytic leukemia (CLL). The company also announced a new, next-generation product candidate for clinical evaluation and provided an update on its product pipeline.

TRU-016 for CLL and NHL

Trubion today announced that patient dosing has commenced in its Phase 1/2 clinical trial of TRU-016 for CLL. The open label clinical trial is composed of two parts: a Phase 1 dose escalation study designed to evaluate the safety, tolerability and pharmacokinetics of TRU-016; and a Phase 2 expansion cohort designed to further evaluate safety and to estimate clinical activity of TRU- 016 in patients with previously treated CLL or small lymphocytic leukemia. Trubion currently retains all development and commercialization rights for the TRU-016 program.

This Phase 1/2 clinical trial is designed to enroll patients who have undergone at least one prior therapy and have relapsed CLL or small lymphocytic leukemia. Efficacy will be evaluated according to disease response and progression status per the International Response Criteria for CLL. Participants will receive intravenous administration of TRU-016 over a four- week period.

"This is an important milestone for our proprietary program and we look fo
'/>"/>

SOURCE Trubion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Trubion Announces Initiation of Phase I/II Clinical Trial of TRU-015 for the Treatment of B-Cell Non-Hodgkins Lymphoma
2. Trubion Pharmaceuticals Announces Presentation of Positive Data From Phase IIb and Re-treatment Studies With TRU-015 in Patients With Rheumatoid Arthritis
3. Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
4. Repligen Initiates Phase 3 Clinical Trial of RG1068 for Pancreatic MRI Imaging
5. Metabolex Initiates Phase 1 Trial of MBX-2982
6. Phosphagenics Initiates its Phase 2 Clinical Trial in Type 1 Diabetes
7. Nventa Enrolls and Initiates Dosing of Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial
8. Ception Therapeutics Initiates Phase II/III Clinical Trial for Its Lead Product Reslizumab in Eosinophilic Esophagitis (EE) in Children
9. Pharmacopeia Initiates Second Phase 2 Hypertension Study with PS433540 (DARA)
10. Phosphagenics Initiates U.S. Clinical Trials for Its Topical Retinoic Acid
11. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 2014 Radiology information system ... used to store, manipulate, and distribute patient radiological ... tracking and scheduling system, result reporting, and an ... HIS and other databases improves the hospital workflow. ... scheduling, patient list management, radiology department workflow management, ...
(Date:12/19/2014)... 2014 Research and Markets ( ... "Micro Market Monitor: North American Dermatology Diagnostic ... http://photos.prnewswire.com/prnh/20130307/600769 ... which has resulted in fueling the overall demand ... purpose of these dermatology devices is to assist ...
(Date:12/19/2014)... -- Decision Resources Group finds that the laparoscopic device market ... increase to a value of over $4.3 billion by ... the large direct energy device market. In particular, premium-priced ... to the advantages they offer and as new products ... Resources Group,s coverage of the U.S. laparoscopic device market: ...
Breaking Medicine Technology:The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 2The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 3Micro Market Monitor: North American Dermatology Diagnostic Devices Market 2Micro Market Monitor: North American Dermatology Diagnostic Devices Market 3U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023 2U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023 3
(Date:12/19/2014)... 2014 The Plantrician Project ... educational events, tools and resources for healthcare professionals ... , the world’s leading online cooking school, have ... being needs: Culinary Rx. As an online food ... Rx, scheduled for debut spring 2015, will be ...
(Date:12/19/2014)... Eufaula, Oklahoma, located just 9 miles ... state’s largest lake with more than 600 miles of ... a little more than 3,000 residents, hosted its annual ... 6th of December. , Featuring Santa, Christmas lights and ... on Main Street. Narconon Arrowhead’s parade float participated ...
(Date:12/19/2014)... The Medspa at Hendrick in Abilene, TX ... cosmetic brand Juvéderm. Voluma XC treats volume loss in ... at Hendrick is pleased to be able to offer ... its clients. , Voluma is the first and only ... the mid-face and cheek area. This non-invasive treatment targets ...
(Date:12/19/2014)... 19, 2014 (HealthDay News) -- The intestinal bacteria that ... ulcerative colitis, may be inherited, researchers report. The ... , could help in efforts to prevent the disease ... colitis, the study authors added. "The intestinal bacteria, ... age can have a big impact on your health ...
(Date:12/19/2014)... 19, 2014 (HealthDay News) -- Injectable drug users who ... suicide attempt rate of other substance users, a new ... associated with the risk of suicide attempt and completed ... of Montreal, said in a university news release. "However, ... wanted to know who among substance users were actually ...
Breaking Medicine News(10 mins):Health News:The Plantrician Project and the Rouxbe Cooking School Join Forces to Develop Culinary Rx – a Plant-Prescription Course 2Health News:The Plantrician Project and the Rouxbe Cooking School Join Forces to Develop Culinary Rx – a Plant-Prescription Course 3Health News:The Plantrician Project and the Rouxbe Cooking School Join Forces to Develop Culinary Rx – a Plant-Prescription Course 4Health News:Narconon Arrowhead Debuts Float at Checotah and Eufaula Christmas Parades 2Health News:Narconon Arrowhead Debuts Float at Checotah and Eufaula Christmas Parades 3Health News:Breakthrough New Injectable Dermal Filler Voluma XC Offered by The MedSpa at Hendrick 2Health News:Crohn's, Colitis May Have Genetic Underpinnings, Study Finds 2Health News:Cocaine, Amphetamines May Up Injection Drug Users' Suicide Risk 2
... It's already been established that type 2 diabetes increases the ... also a link between type 1 diabetes and this type ... but still, those with type 1 diabetes have a likelihood ... in non-diabetics. This is similar to the risk those with ...
... disorder and other mental health conditions are potentially around the ... ,The findings, which were based on analysis of ... 6 in the American Journal of Medical Genetics. ... quantum leap in psychiatry,' said the study's lead author, Robert ...
... said that India, home to 12 million blind people, will ... five years before the World Health Organisation (WHO) deadline of ... little above 1.1 percent. And looking at the progress we ... are quite sure that the WHO target of 0.3 percent ...
... by a University of Leicester geologist was recently used by ... exposure of UK troops to depleted uranium (DU) during the ... Professor of Isotope Geology, developed the test with Postdoctoral Fellow ... Frankfurt, Germany, and his colleague Matt Horstwood at the British ...
... the genetic make-up using blood samples to detect certain ... in practice//. Now, scientists have gone a bit further ... that might reveal the latent tendencies in people to ... disorder. ,Such tests would not dictate who ...
... it may be possible to detect certain mental health conditions ... scientists studied the genetic information in immature white blood cells. ... is a quantum leap in psychiatry," said the study's lead ... UI Roy J. and Lucille A. Carver College of Medicine. ...
Cached Medicine News:Health News:Blood Tests may Be Possible for Mental Health Conditions 2Health News:DU Test Finds UK Troops Uranium Free 2Health News:Genetic Tests to Reveal ‘substance Abuse’ Tendenci 2Health News:Genetic Tests to Reveal ‘substance Abuse’ Tendenci 3Health News:Mental Health Conditions Could Be Detected With Blood Tests 2
... based on SIREMOBIL Iso-C, the first truly ... intra-operative 3D-Mode, the 3D-dataset is immediately available ... movement. This allows the surgeon to perform ... the procedure. This 3D capability is especially ...
... restricted to small central fields, unconventional ... full field capable, all encompassing systems ... ever need to ensure the most ... also include the most important and ...
... II-i series is a wheelchair accessible, computerized ... field. ,By using SITA, the expert operating ... up to 70%. ,A patented aspherically shaped ... increase patient comfort while testing out to ...
... results. The Kowa AP-340 a new concept ... system of ultimate simplicity. Quick, comfortable procedure ... a compact, unique design profile weighing just ... features.The integration of CRT display and instrumentation ...
Medicine Products: